KRANZLER JAY D 4
4 · AVENUE THERAPEUTICS, INC. · Filed Jun 16, 2020
Insider Transaction Report
Form 4
KRANZLER JAY D
Director
Transactions
- Award
Common Stock
2020-06-16+10,000→ 84,663 total
Footnotes (2)
- [F1]Common Stock vests upon the earliest to occur of the following: (i) Grantee's death or disability; (ii) a change in control of Avenue Therapeutics, Inc.; or (iii) the Second Stage Closing with InvaGen.
- [F2]Includes 84,663 shares of restricted stock.